- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07469995
The Effect of Grocery Support Dose on Food Insecurity and Disease Control Among Covered California Members With Diabetes or Hypertension
March 12, 2026 updated by: University of California, San Francisco
This continuation study is a pragmatic randomized controlled trial (RCT) of Covered California's Grocery Support Program among low-income participants with diabetes or hypertension.
This pragmatic RCT will compare the efficacy of providing different benefit amounts ($80 vs. $120) via a monthly food card benefit for households where at least one adult has diabetes and/or hypertension and incomes below 250% of the federal poverty level (FPL).
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Detailed Description
In 2024, Covered California initiated multiple Population Health Investments (PopHIs) based on funds collected by participating plans if they failed to meet a set of quality benchmarks related to diabetes control, blood pressure control, colorectal cancer screening, and childhood immunizations.
One priority area for the PopHIs was food insecurity among patients who manage diabetes and/or hypertension.
Food insecurity, defined by the US Department of Agriculture (USDA) as a "lack of access to enough food for an active, healthy life" effects 18% of newly enrolled Covered California members.
Food insecurity is more pronounced and is associated with poor clinical outcomes and more avoidable and costly healthcare utilization among individuals who manage diabetes and/or hypertension.
In 2025, Covered California initiated the first year of the food insecurity PopHI comparing the impact of an $80 monthly grocery support cash card for 12-months versus a one-time payment at the end of 12-months among a low-income cohort with food insecurity and a chronic condition.
Building off year one learnings, Covered California tailored their program design and benefit amount based on findings.
While produce prescription and grocery support programs have been shown to reduce food insecurity and improve diet quality, key implementation questions most importantly the impact of varying doses, remain to be understood.
The goal of the proposed research is to evaluate the impact of two different doses of a 12-month grocery support program on participant food insecurity and health outcomes among a cohort of individuals with diabetes and/or hypertension.
Participants were invited to enroll in the program if they were active members of Covered California at the time of enrollment and had a documented diabetes and/or hypertension diagnosis and an income at or below 250% of the FPL.
Participants were randomly assigned to receive either an $80 or $120 reusable semi-restricted cash card re-loaded monthly for one year (payments in both arms adjusted based on household size).
Retailers are restricted to food retailers, which includes retailers that do sell non-food goods.
The study has four main data sources: survey data from surveys repeated at baseline and 12-months; cash card spending data; qualitative participant interview data, and administrative claims data.
Study Type
Interventional
Enrollment (Estimated)
4450
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Laura Gottlieb, MD, MPH
- Phone Number: 415-509-8976
- Email: siren@ucsf.edu
Study Contact Backup
- Name: Emma L Tucher, PhD
- Phone Number: 415-205-4522
- Email: emma.tucher@ucsf.edu
Study Locations
-
-
California
-
San Francisco, California, United States, 94107
- SIREN 675 18th Street
-
Contact:
- Laura Gottlieb, MD, MPH
- Phone Number: 415-509-8976
- Email: siren@ucsf.edu
-
Sub-Investigator:
- Emma Tucher, PhD
-
Principal Investigator:
- Laura M Gottlieb, MD, MPH
-
Principal Investigator:
- Danielle Hessler Jones, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Active Covered California member
- Adult >= 18 years of age
- Has a diabetes and or hypertension diagnosis identifiable in Covered California's administrative claims
- Income <250% FPL
Exclusion Criteria:
- No longer a Covered California member
- $0 spending in year 1 grocery support program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Monthly $80 grocery support program
The intervention entails the provision of an $80 monthly payment (adjusted by household size) in the form of a re-loadable cash card to be used at food retailers including food retailers who sell non-food item.
|
$80 monthly (adjusted by household size), re-loadable cash card for use at food retailers
|
|
Active Comparator: Monthly $120 grocery support program
The active comparator entails the provision of a $120 monthly payment (adjusted by household size) in the form of a re-loadable cash card to be used at food retailers including food retailers who sell non-food item.
|
$120 monthly (adjusted by household size), re-loadable cash card for use at food retailers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Food insecurity status
Time Frame: Baseline, 12 months
|
Measured by 2-item Hunger Vital Sign, a validated tool to assess food insecurity.
Higher scores indicate greater food insecurity.
|
Baseline, 12 months
|
|
Change in HbA1c
Time Frame: Baseline, 12 months
|
Change in self-reported HbA1c from baseline by study arm.
|
Baseline, 12 months
|
|
Change in frequency of experiences of hypoglycemia
Time Frame: Baseline, 12 months
|
Measured using the change in self-reported frequency per week that a participant experiences hypoglycemia.
|
Baseline, 12 months
|
|
Change in blood pressure
Time Frame: Baseline, 12 months
|
Change in self-reported systolic and diastolic blood pressure from baseline by study arm.
|
Baseline, 12 months
|
|
Change in diabetes and/or hypertension distress
Time Frame: Baseline, 12 months
|
The change is measured using an adapted 10-item version of the validated 17-item Diabetes and Hypertension Distress Scale, where each item ranges from 1-5, mean score ranges from 1-5, and total score is 10-50 with higher scores indicating greater diabetes- and hypertension-related distress.
|
Baseline, 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nutrition security
Time Frame: Baseline, 12 months
|
Measured using the one-item response allowing calculation of the proportion of participants that report difficulty getting and eating healthy foods.
|
Baseline, 12 months
|
|
Diet quality
Time Frame: Baseline, 12 months
|
Measured using the self-reported number of servings of vegetables or number of days where higher fat foods were consumed during the past 7 days, by study arm.
|
Baseline, 12 months
|
|
Acute health care utilization
Time Frame: 2 years before study start until 12 months after
|
Proportion of participants that used the ED or had a treat and release ED or observation room visit and number of visits by study arm.
|
2 years before study start until 12 months after
|
|
Hospital admissions
Time Frame: 2 years before study start until 12 months after
|
Proportion of participants who were hospitalized at least once and count of total hospitalizations from baseline to 12 months by study arm.
|
2 years before study start until 12 months after
|
|
Hospital readmissions
Time Frame: 2 years before study start until 13 months after
|
Proportion of participants who were re-hospitalized within 30-days of the index hospitalization by study arm.
|
2 years before study start until 13 months after
|
|
Outpatient visits
Time Frame: 2 years before study start until 12 months after
|
Number of primary care provider, specialist, mental health, and addiction medicine visits across the 12 month study period by study arm.
|
2 years before study start until 12 months after
|
|
Self-rated physical and mental health
Time Frame: Baseline, 12 months
|
Measured as the change in self-rated overall, physical, and mental health reported on a 0 to 5-response (excellent to poor) scale by study arm.
Higher score corresponds to better self-rated health.
|
Baseline, 12 months
|
|
Self-reported medication adherence
Time Frame: Baseline, 12 months
|
Measured as an affirmative response to cost-based medication nonadherence and the change in a single-item question asking patients how many days (out of 7) they missed taking one of their medications.
Changes in the number of days reported from baseline by study arm.
|
Baseline, 12 months
|
|
Medication adherence
Time Frame: 2 years before study start until 12 months after
|
Measured using medical claims data and calculated based on daily supply.
|
2 years before study start until 12 months after
|
|
Medication count
Time Frame: 2 years before study start until 12 months after
|
Measured using the survey and medical claims as the total number of medications that the participant had at baseline and across the 12-month study period.
|
2 years before study start until 12 months after
|
|
Cost-based changes to primary care or medication use
Time Frame: Baseline, 12 months
|
Measured using a 5-response question (never to often) to delays to medical care because of cost and a binary (yes/no) response to a question about cost-related medication nonadherence.
|
Baseline, 12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Low food security
Time Frame: Baseline, 12 months
|
Measured as the change in the proportion of participants with low food security.
Low food security will be defined as one or more item answered with "Often true" in the Hunger Vital Sign.
Change in proportion of participants with low food security, from baseline to 12 months.
|
Baseline, 12 months
|
|
Nutrition security
Time Frame: Baseline, 12 months
|
Measured using the 14-response options providing reasons why respondents have difficulty eating or not eating healthy foods.
|
Baseline, 12 months
|
|
Self-reported utilization
Time Frame: Baseline, 12 months
|
Measured based on the change in self-reported hospitalizations, doctors visits, and ED visits within the past 12 months measured as continuous outcome between 0 and 100 or more.
|
Baseline, 12 months
|
|
Other social risks
Time Frame: Baseline, 12 months
|
Measured using the change in severity or presence of other social risks assessed using validated survey items for housing insecurity, transportation barriers, and financial strain.
|
Baseline, 12 months
|
|
Trade-offs
Time Frame: Baseline, 12 months
|
Measured using the proportion of participants who report sometimes or often making trade offs between paying for food and paying for medications or medical care, utilities, rent or mortgage, transportation, and education.
|
Baseline, 12 months
|
|
Self-rated health
Time Frame: Baseline, 12 months
|
Measured using the validated 10-item measure (PROMIS-10) to assess self-rated health, quality of life, mental and physical health, social satisfaction, ability to carry out roles, ability to carry out everyday physical activities, experiences of fatigue, frequency of emotional problems, and average pain.
Analysis will assess change in overall measure by study arm.
|
Baseline, 12 months
|
|
Perceived stress
Time Frame: Baseline, 12 months
|
Measured using changes in self-report based on a validated, 10-item perceived stress scale.
|
Baseline, 12 months
|
|
Self-efficacy
Time Frame: Baseline, 12 months
|
Measured using changes in participant responses across the 9-item validated self-efficacy scale.
|
Baseline, 12 months
|
|
Chronic disease self-efficacy
Time Frame: Baseline, 12 months
|
Measured using changes in participant responses across the validated, two-item chronic disease self-efficacy scale.
|
Baseline, 12 months
|
|
Utilization characteristics
Time Frame: 2 years before study start until 12 months after.
|
Measured using claims data to analyze utilization characteristics e.g., length of stay (total days, average number of days per stay), days until next admit, and total cost of admissions across the 12 month study period.
|
2 years before study start until 12 months after.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Laura M Gottlieb, MD, MPH, University of California, San Francisco
- Principal Investigator: Danielle Hessler Jones, PhD, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 10, 2026
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
March 10, 2026
First Submitted That Met QC Criteria
March 10, 2026
First Posted (Actual)
March 13, 2026
Study Record Updates
Last Update Posted (Actual)
March 16, 2026
Last Update Submitted That Met QC Criteria
March 12, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21C02711
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Data is not available without a data use agreement with Covered California to protect patient health information in alignment with secure data storage and research ethical practices in alignment with our IRB protocol.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on $80 Grocery Support Monthly Program
-
University of California, San FranciscoCovered CaliforniaActive, not recruitingFood Insecurity | Low-Income Population | Chronic Conditions, Multiple | Chronic ConditionsUnited States
-
Clinical Evaluation Research Unit at Kingston General...Canadian Institutes of Health Research (CIHR); Griffith UniversityUnknownCritical IllnessUnited States, Canada, Australia
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; United States Department of Agriculture... and other collaboratorsCompleted
-
Alison GustafsonInstacart Health; Kentucky Association of Health PlansCompletedHypertension | Type 2 Diabetes MellitusUnited States
-
Monash UniversityNovartis PharmaceuticalsTerminatedCerebrovascular Disease | Coronary Heart Disease (CHD) | Peripheral Arterial Disease (PAD) | Atherosclerotic Cardiovascular Disease (ASCVD)Australia
-
Kelly BooneChildren's Hospital Medical Center, CincinnatiTerminatedInflammatory Bowel Diseases | Pediatric Ulcerative Colitis | Pediatric Crohns DiseaseUnited States
-
Dana-Farber Cancer InstituteWithdrawnLow-grade Glioma | Survivorship | Care Giving BurdenUnited States
-
University of Sao Paulo General HospitalUnknown
-
University of ZurichCompletedKidney Transplantation | Rental TransplantationSwitzerland